Walleye Capital
SPPI

Walleye Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Walleye Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-111,900
Closed -$407K – 1872
2019
Q4 		$407K Buy
+111,900
New +$904K 0.03% 782

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Capital's SPPI Position: Q2 2020 in Review

Walleye Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2020, closing a stake of 230,839 shares — an estimated $537K sold.

Walleye Capital first reported a position in SPPI in Q3 2018 and held it in 3 quarters. The position peaked at $537K in Q1 2020. 158 funds tracked by Wall St. Rank hold SPPI as of Q2 2020.

  • Walleye Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Walleye Capital sold 230,839 Spectrum Pharmaceuticals Inc shares in Q2 2020, an estimated $537K.
  • Walleye Capital first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 3 quarters.
  • Walleye Capital's Spectrum Pharmaceuticals Inc position peaked at $537K in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2020.

Based on Walleye Capital's 13F filing for Q2 2020, filed 14 Aug 2020.